CASP3 and cancer: F-UBE-HPC acts on CLS-354 cancer cells, considerably increasing cellular oxidative stress and caspase 3/7 activity, triggering nuclear condensation and autophagy, inducing cell cycle arrest in G0/G1, and blocking DNA synthesis.